Skip to main content
OpenTrials

Clinical trial condition

Non-Squamous Non-Small Cell Lung Cancer

Explore clinical trials studying Non-Squamous Non-Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

67 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Non-Squamous Non-Small Cell Lung Cancer trial results

Completed

A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer

NCT03329911

Conditions
Non-Squamous Non-Small Cell Lung Cancer
Locations
  • The First Affiliated Hospital of Xiamen University Xiamen, China
  • Clinical Medical Research S.C. Orizaba, Mexico
  • National Hospital Oncology Bloemfontein, South Africa
  • Baskent University Ankara Hospital Ankara, Turkey (Türkiye)
View Trial Details
Completed

Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers

NCT02264990

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Clearview Cancer Institute /ID# 131434 Huntsville, Alabama, United States
  • University of South Alabama /ID# 131518 Mobile, Alabama, United States
  • Highlands Oncology Group /ID# 131250 Springdale, Arkansas, United States
  • CBCC Global Research, Inc. at /ID# 132709 Bakersfield, California, United States
View all 140 locations
View Trial Details
Completed

A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy

NCT02008227

Conditions
Non-Squamous Non-Small Cell Lung Cancer
Locations
  • Comprehensive Blood/Cancer Ctr Bakersfield, California, United States
  • Roy & Patricia Disney Family Cancer Center Burbank, California, United States
  • St. Jude Heritage Healthcare; Virgiia K.Crosson Can Ctr Fullerton, California, United States
  • Kaiser Permanente - Hayward Hayward, California, United States
View all 208 locations
View Trial Details
Completed

A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations

NCT01260181

Conditions
Non-Squamous Non-Small Cell Lung Cancer
Locations
  • Hospital Infante D. Pedro; Servico de Oncologia Medica Aveiro, Portugal
  • Hospital Geral; Servico de Pneumologia Coimbra, Portugal
  • IPO de Lisboa; Servico de Pneumologia Lisbon, Portugal
  • Hospital Santo Antonio dos Capuchos;Servico de Oncologia Medica Lisbon, Portugal
View Trial Details
Completed

A Study on the Correlation Between Tarceva (Erlotinib) - Induced Rash and Efficacy in EGFR Mutated Participants With Advanced Non-Small Cell Lung Cancer Receiving First-Line Therapy

NCT01174563

Conditions
Non-Squamous Non-Small Cell Lung Cancer
Locations
  • Haemek Hospital; Oncology Afula, Israel
  • Barzilai; Oncology Ashkelon, Israel
  • Soroka Medical Center; Oncology Dept Beersheba, Israel
  • Carmel Hospital; Oncology Unit Haifa, Israel
View all 16 locations
View Trial Details
Completed

A Study of Tarceva (Erlotinib) as First Line Therapy in Participants With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations

NCT01310036

Conditions
Non-Squamous Non-Small Cell Lung Cancer
Locations
  • Princess Margaret Hospital; Oncology Hong Kong
  • Queen Elizabeth Hospital; Clinical Oncology Hong Kong
  • Prince of Wales Hosp; Dept. Of Clinical Onc Shatin, Hong Kong
  • Seoul National University Bundang Hospital Gyeonggi-do, South Korea
View all 22 locations
View Trial Details

Related conditions